Viret Jean-Frederic

Viret Jean-Frederic serves as the Chief Financial Officer at NGM Biopharmaceuticals, Inc., a company focused on developing innovative therapies in the healthcare sector. His recent public disclosures, tracked through SEC Form 4 filings, include three transactions from December 4, 2023, to April 8, 2024, all related to NGM. The largest disclosed move during this period was valued at $346,500 on April 8, 2024, highlighting his active engagement in the firm's financial activities.